Can anti-dopamine D2 receptor autoantibodies explain fluctuations of tic severity?
- PMID: 32662071
- DOI: 10.1111/dmcn.14626
Can anti-dopamine D2 receptor autoantibodies explain fluctuations of tic severity?
Comment on
-
Anti-dopamine D2 receptor antibodies in chronic tic disorders.Dev Med Child Neurol. 2020 Oct;62(10):1205-1212. doi: 10.1111/dmcn.14613. Epub 2020 Jul 9. Dev Med Child Neurol. 2020. PMID: 32644201
References
-
- Maia TV, Conceição VA. The roles of phasic and tonic dopamine in tic learning and expression. Biol Psychiatry 2017; 82: 401-12.
-
- Maia TV, Conceição VA. Dopaminergic disturbances in Tourette syndrome: an integrative account. Biol Psychiatry 2018; 84: 332-44.
-
- Addabbo F, Baglioni V, Schrag A, et al. Anti-dopamine D2 receptor antibodies in chronic tic disorders: potential link to fluctuations of tic severity. Dev Med Child Neurol 2020. https://doi.org/10.1111/dmcn.14613
-
- Pollak TA, Beck K, Irani SR, et al. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications. Psychopharmacology (Berl) 2016; 233: 1605-21.
-
- Sinmaz N, Tea F, Pilli D, et al. Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders. Acta Neuropathol Commun 2016; 4: 126.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources